Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HSK3486 injectable emulsion for efficacy and safety in induction and maintenance of general anesthesia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HSK3486 injectable emulsion (HSK3486)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Induction and Maintenance of General Anesthesia | Phase 2 | Status: COMPLETED